BioCatalyst

REGN7508, Apixaban, Enoxaparin — catalyst calendar

1 verified catalyst event(s) referencing REGN7508, Apixaban, Enoxaparin, each linked to its official source. Verified as of 2026-10-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-20
in 4mo
ESTIMATED
 READOUT
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee
Phase 3 · Venous Thromboembolism (VTE)
 REGN REGENERON PHARMACEUTICALS, I REGN7508, Apixaban, Enoxaparin ClinicalTrials.gov ↗
✓ Source-checked 2026-10-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.